[18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography localizes residual thyroid cancer in patients with negative diagnostic (131)I whole body scans and elevated serum thyroglobulin levels.
暂无分享,去创建一个
S. Larson | H. Macapinlac | J. Rosai | T. Akhurst | R. Finn | S. Yeh | R. Robbins | W. Wang | H. Macapinlac | Weiping Wang
[1] J. Ruhlmann,et al. Comparison of 18FDG-PET with 131iodine and 99mTc-sestamibi scintigraphy in differentiated thyroid cancer. , 1997, Thyroid : official journal of the American Thyroid Association.
[2] J. Hanke,et al. Fluorine-18-FDG and iodine-131-iodide uptake in thyroid cancer. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[3] A. Bockisch,et al. Technetium-99m-furifosmin in the follow-up of differentiated thyroid carcinoma. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[4] N. Jaffe,et al. Intraarterial cis‐platinum for patients with inoperable skeletal tumors , 1981, Cancer.
[5] O. Schober,et al. Positron emission tomography with F-18-deoxyglucose in patients with differentiated thyroid carcinoma, elevated thyroglobulin levels, and negative iodine scans , 1998, Langenbeck's Archives of Surgery.
[6] U. Feine. Fluor-18-deoxyglucose positron emission tomography in differentiated thyroid cancer. , 1998, European journal of endocrinology.
[7] C. Spencer,et al. Current status and performance goals for serum thyrotropin (TSH) assays. , 1996, Clinical chemistry.
[8] I. Mcdougall. 131I treatment of 131I negative whole body scan, and positive thyroglobulin in differentiated thyroid carcinoma: what is being treated? , 1997, Thyroid : official journal of the American Thyroid Association.
[9] L. Adler,et al. Positron emission tomography of thyroid masses. , 1993, Thyroid : official journal of the American Thyroid Association.
[10] R. Wahl,et al. Uptake of 18-fluoro-2-deoxy-D-glucose by thyroid cancer: implications for diagnosis and therapy. , 1993, The Journal of clinical endocrinology and metabolism.
[11] A. Pinchera,et al. Therapeutic doses of iodine-131 reveal undiagnosed metastases in thyroid cancer patients with detectable serum thyroglobulin levels. , 1987, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[12] T. Endo,et al. The regulation of two distinct glucose transporter (GLUT1 and GLUT4) gene expressions in cultured rat thyroid cells by thyrotropin. , 1992, Endocrinology.
[13] T G Turkington,et al. Performance characteristics of a whole-body PET scanner. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[14] Taylor Murray,et al. Cancer statistics, 1998 , 1998, CA: a cancer journal for clinicians.
[15] E. Baudin,et al. Serum thyroglobulin determination in the follow-up of patients with differentiated thyroid carcinoma. , 1998, European journal of endocrinology.
[16] M. Clausen,et al. Histological verification of positive fluorine-18 fluorodeoxyglucose findings in patients with differentiated thyroid cancer , 1998, Langenbeck's Archives of Surgery.
[17] H. Joensuu,et al. Imaging of metastases of thyroid carcinoma with fluorine-18 fluorodeoxyglucose. , 1987, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[18] H. Macapinlac,et al. Radioiodine treatment of thyroid cancer with the aid of recombinant human thyrotropin. , 1998, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[19] J. Miller,et al. Metastatic Papillary Thyroid Carcinoma with Normal Serum Thyroglobulin Level , 1988, Clinical nuclear medicine.
[20] M. Dietlein,et al. Fluorine-18 fluorodeoxyglucose positron emission tomography and iodine-131 whole-body scintigraphy in the follow-up of differentiated thyroid cancer , 1997, European Journal of Nuclear Medicine.
[21] J. Høie,et al. Distant metastases in papillary thyroid cancer. A review of 91 patients , 1988, Cancer.
[22] J. Hanke,et al. [18FDG whole-body PET in differentiated thyroid carcinoma. Flipflop in uptake patterns of 18FDG and 131I]. , 1995, Nuklearmedizin. Nuclear medicine.
[23] N. Sadato,et al. Fluorine-18-fluorodeoxyglucose PET versus thallium-201 scintigraphy evaluation of thyroid tumors. , 1998, Journal of Nuclear Medicine.
[24] M. Sonenberg,et al. The relation of radioiodine dosimetry to results and complications in the treatment of metastatic thyroid cancer. , 1962, The American journal of roentgenology, radium therapy, and nuclear medicine.
[25] S. Jhiang,et al. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. , 1994, The American journal of medicine.
[26] T. Fukumura,et al. Assessment of response to cancer therapy using fluorine-18-fluorodeoxyglucose and positron emission tomography. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.